Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 10-2008 | 07-2008 | 04-2008 | 01-2008 | 10-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 670 | 246 | 50 | 102 | 78 |
| Receivables | 16 | 112 | 161 | 243 | 38 |
| TOTAL | $691 | $357 | $213 | $359 | $134 |
| Non-Current Assets | |||||
| PPE Net | 3,072 | 3,461 | 3,386 | 3,878 | 3,662 |
| TOTAL | $3,072 | $3,461 | $3,386 | $3,878 | $3,662 |
| Total Assets | $3,763 | $3,819 | $3,600 | $4,236 | $3,796 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 273 | 727 | 722 | N/A | N/A |
| Accounts payable and accrued liabilities | 3 | 19 | 21 | 120 | 19 |
| Accrued Expenses | N/A | N/A | N/A | 21 | 11 |
| Other current liabilities | 2 | 25 | 18 | 13 | 321 |
| TOTAL | $277 | $772 | $761 | $886 | $401 |
| Non-Current Liabilities | |||||
| Long Term Debt | 724 | N/A | N/A | N/A | N/A |
| TOTAL | $724 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,001 | $772 | $761 | $886 | $401 |
| Shareholders' Equity | |||||
| Common Shares | 24 | 24 | 24 | 24 | 24 |
| Retained earnings | -2,618 | -2,298 | -2,239 | -1,706 | -1,640 |
| TOTAL | $2,762 | $3,046 | $2,839 | $3,351 | $3,395 |
| Total Liabilities And Equity | $3,763 | $3,819 | $3,600 | $4,236 | $3,796 |